摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5-nitro-2-pyrrolidin-1-yl-3H-pyrimidin-4-one | 1562399-11-4

中文名称
——
中文别名
——
英文名称
5-nitro-2-pyrrolidin-1-yl-3H-pyrimidin-4-one
英文别名
5-nitro-2-(pyrrolidin-1-yl)-4(3H)-pyrimidinone;5-nitro-2-pyrrolidin-1-yl-1H-pyrimidin-6-one
5-nitro-2-pyrrolidin-1-yl-3H-pyrimidin-4-one化学式
CAS
1562399-11-4
化学式
C8H10N4O3
mdl
——
分子量
210.192
InChiKey
UPERKEYJSOMYSV-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -0.2
  • 重原子数:
    15
  • 可旋转键数:
    1
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.5
  • 拓扑面积:
    90.5
  • 氢给体数:
    1
  • 氢受体数:
    4

反应信息

  • 作为反应物:
    描述:
    5-nitro-2-pyrrolidin-1-yl-3H-pyrimidin-4-one盐酸copper(l) iodide三乙胺对甲苯磺酰氯 、 tin(ll) chloride 、 N,N'-二甲基乙二胺 作用下, 以 乙醇N,N-二甲基甲酰胺乙腈 为溶剂, 反应 4.0h, 生成 1-(2-Pyrrolidin-1-ylpyrimido[4,5-b][1,4]benzothiazin-5-yl)ethanone
    参考文献:
    名称:
    Diazaphenoxazines and Diazaphenothiazines: Synthesis of the “Correct” Isomers Reveals They Are Highly Reactive Radical-Trapping Antioxidants
    摘要:
    The preparation of 2,4-diazaphenothiazines and 2,4-diazaphenoxazines via a copper-catalyzed intramolecular amination is described. Literature approaches-mhich utilize easily accessed (2'-aminophenyl) 4-pyri(mi)dyl sulfides undergo a Smiles rearrangement that gives rise to the 1,3-dinza derivatives instead, confirmed by X-ray crystallography. Inversion of the polarity of the cyclization avoids the rearrangement and affords the desired,products. Preliminary kinetic studies suggest :that 2,4-diazaphenothiazines and diazaphenoxazines, but not the 1,3-diaza isomers, are remarkably potent radical-trapping antioxidants.
    DOI:
    10.1021/acs.orglett.7b00615
  • 作为产物:
    描述:
    2-(pyrrolidin-1-yl)-4(3H)-pyrimidinone硫酸硝酸 作用下, 以72%的产率得到5-nitro-2-pyrrolidin-1-yl-3H-pyrimidin-4-one
    参考文献:
    名称:
    Diazaphenoxazines and Diazaphenothiazines: Synthesis of the “Correct” Isomers Reveals They Are Highly Reactive Radical-Trapping Antioxidants
    摘要:
    The preparation of 2,4-diazaphenothiazines and 2,4-diazaphenoxazines via a copper-catalyzed intramolecular amination is described. Literature approaches-mhich utilize easily accessed (2'-aminophenyl) 4-pyri(mi)dyl sulfides undergo a Smiles rearrangement that gives rise to the 1,3-dinza derivatives instead, confirmed by X-ray crystallography. Inversion of the polarity of the cyclization avoids the rearrangement and affords the desired,products. Preliminary kinetic studies suggest :that 2,4-diazaphenothiazines and diazaphenoxazines, but not the 1,3-diaza isomers, are remarkably potent radical-trapping antioxidants.
    DOI:
    10.1021/acs.orglett.7b00615
点击查看最新优质反应信息

文献信息

  • Identification of Highly Efficacious Glucocorticoid Receptor Agonists with a Potential for Reduced Clinical Bone Side Effects
    作者:Christian Harcken、Doris Riether、Daniel Kuzmich、Pingrong Liu、Raj Betageri、Mark Ralph、Michel Emmanuel、Jonathan T. Reeves、Angela Berry、Donald Souza、Richard M. Nelson、Alison Kukulka、Tazmeen N. Fadra、Ljiljana Zuvela-Jelaska、Roger Dinallo、Jörg Bentzien、Gerald H. Nabozny、David S. Thomson
    DOI:10.1021/jm4019178
    日期:2014.2.27
    Synthesis and structure-activity relationship (SAR) of a series of nonsteroidal glucocorticoid receptor (GR) agonists are described. These compounds contain "diazaindole" moieties and display different transcriptional regulatory profiles in vitro and are considered "dissociated" between gene transrepression and transactivation. The lead optimization effort described in this article focused in particular on limiting the transactivation of genes which result in bone side effects and these were assessed in vitro in MG-63 osteosarcoma cells, leading to the identification of (R)-18 and (R)-21. These compounds maintained anti-inflammatory activity in vivo in collagen induced arthritis studies in mouse but had reduced effects on bone relevant parameters compared to the widely used synthetic glucocorticoid prednisolone 2 in vivo. To our knowledge, we are the first to report on selective glucocorticoid ligands with reduced bone loss in a preclinical in vivo model.
查看更多